Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled Comparability Study to Compare Two Presentations of Cagrilintide for Weight Management in Participants With Overweight or Obesity

NCT07745504 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07745504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07745504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled Comparability Study to Compare Two Presentations of Cagrilintide for Weight Management in Participants With Overweight or Obesity
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Recruiting
Start date
August 4, 2026
Completion date
July 6, 2027
Enrollment
285 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight